JP2022529727A5 - - Google Patents
Info
- Publication number
- JP2022529727A5 JP2022529727A5 JP2021562914A JP2021562914A JP2022529727A5 JP 2022529727 A5 JP2022529727 A5 JP 2022529727A5 JP 2021562914 A JP2021562914 A JP 2021562914A JP 2021562914 A JP2021562914 A JP 2021562914A JP 2022529727 A5 JP2022529727 A5 JP 2022529727A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- linker
- binding
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962838255P | 2019-04-24 | 2019-04-24 | |
| US62/838,255 | 2019-04-24 | ||
| US201962841739P | 2019-05-01 | 2019-05-01 | |
| US62/841,739 | 2019-05-01 | ||
| PCT/US2020/029618 WO2020219748A2 (en) | 2019-04-24 | 2020-04-23 | Anti-cd117 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022529727A JP2022529727A (ja) | 2022-06-23 |
| JP2022529727A5 true JP2022529727A5 (cg-RX-API-DMAC10.html) | 2022-09-20 |
Family
ID=72941301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562914A Withdrawn JP2022529727A (ja) | 2019-04-24 | 2020-04-23 | Anti-cd117 とその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220177578A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3959243A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2022529727A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020219748A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019217942A1 (en) | 2018-05-11 | 2019-11-14 | Beam Therapeutics Inc. | Methods of substituting pathogenic amino acids using programmable base editor systems |
| WO2022187050A1 (en) * | 2021-03-01 | 2022-09-09 | BioLegend, Inc. | Anti-cd117 agents and compositions and methods for making and using the same |
| IL313568A (en) * | 2021-12-16 | 2024-08-01 | Universit?T Basel | Distinct cell membrane protein variants of CD117 for use in cellular therapy |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120189633A1 (en) * | 2011-01-26 | 2012-07-26 | Kolltan Pharmaceuticals, Inc. | Anti-kit antibodies and uses thereof |
| AR086044A1 (es) * | 2011-05-12 | 2013-11-13 | Imclone Llc | Anticuerpos que se unen especificamente a un dominio extracelular de c-kit y usos de los mismos |
| MX366978B (es) * | 2013-03-15 | 2019-08-01 | Novartis Ag | Conjugados de anticuerpo - farmaco. |
| WO2015050959A1 (en) * | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
| US9932410B2 (en) * | 2013-11-05 | 2018-04-03 | Inserm (Institut National De La Sante Et De La Recherche Medicale | Human neutralizing anti-kit antibodies and uses thereof |
| WO2016020791A1 (en) * | 2014-08-05 | 2016-02-11 | Novartis Ag | Ckit antibody drug conjugates |
| US10111966B2 (en) * | 2016-06-17 | 2018-10-30 | Magenta Therapeutics, Inc. | Methods for the depletion of CD117+ cells |
| WO2019084067A1 (en) * | 2017-10-24 | 2019-05-02 | Magenta Therapeutics, Inc. | ANTI-CD117 ANTIBODIES AND METHODS OF USE |
| US10882915B2 (en) * | 2017-10-24 | 2021-01-05 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of CD117+ cells |
| JP2021526525A (ja) * | 2018-06-07 | 2021-10-07 | マジェンタ セラピューティクス インコーポレイテッドMagenta Therapeutics, Inc. | 抗体薬物コンジュゲート(adcs)を用いた治療方法 |
-
2020
- 2020-04-23 JP JP2021562914A patent/JP2022529727A/ja not_active Withdrawn
- 2020-04-23 EP EP20794877.9A patent/EP3959243A4/en not_active Withdrawn
- 2020-04-23 WO PCT/US2020/029618 patent/WO2020219748A2/en not_active Ceased
-
2021
- 2021-10-22 US US17/508,766 patent/US20220177578A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7641452B2 (ja) | Cd117+細胞を減少させるための組成物及び方法 | |
| US11572411B2 (en) | Anti-CD117 antibodies and conjugates | |
| JP7791923B2 (ja) | Cd5+細胞の枯渇のための組成物および方法 | |
| JP7669269B2 (ja) | 抗-cd45抗体及びそのコンジュゲート | |
| JP2025160215A (ja) | Fcサイレンス化抗体薬物コンジュゲート(ADC)及びその使用 | |
| TWI904109B (zh) | 抗cd45抗體及其結合物 | |
| JP2021500375A5 (cg-RX-API-DMAC10.html) | ||
| US20220177575A1 (en) | Anti-cd117 antibodies and uses thereof | |
| JP2022529726A5 (cg-RX-API-DMAC10.html) | ||
| CN111670200A (zh) | 用于耗尽cd2+细胞的组合物和方法 | |
| JP2022530443A5 (cg-RX-API-DMAC10.html) | ||
| EP3958899A2 (en) | Anti-cd117 antibody-drug conjugates and uses thereof | |
| US20220177578A1 (en) | Anti-cd117 antibodies and uses thereof | |
| JP2025172753A (ja) | 自己免疫疾患を治療するための方法および組成物 | |
| CN112154152A (zh) | 抗cd252抗体、缀合物和使用方法 |